United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc - flunisolide (unii: qk4dys664x) (flunisolide anhydrous - unii:78m02aa8kf) - flunisolide 0.25 mg in 1 ml - flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. flunisolide nasal solution should not be used in the presence of untreated localized infection involving the nasal mucosa. hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

bausch & lomb incorporated - flunisolide (unii: qk4dys664x) (flunisolide anhydrous - unii:78m02aa8kf) - flunisolide 0.25 mg in 1 ml - flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. flunisolide nasal solution should not be used in the presence of untreated localized infection involving nasal mucosa. hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - flunisolide (unii: qk4dys664x) (flunisolide anhydrous - unii:78m02aa8kf) - flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. flunisolide nasal solution should not be used in the presence of untreated localized infection involving nasal mucosa. hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - flunisolide (unii: qk4dys664x) (flunisolide anhydrous - unii:78m02aa8kf) - flunisolide 0.25 mg in 1 ml - flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. flunisolide nasal solution should not be used in the presence of untreated localized infection involving nasal mucosa. hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - flunisolide (unii: qk4dys664x) (flunisolide anhydrous - unii:78m02aa8kf) - flunisolide 0.25 mg in 1 ml - flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. flunisolide nasal solution should not be used in the presence of untreated localized infection involving nasal mucosa. hypersensitivity to any of the ingredients.

Canada - English - Health Canada

pharmascience inc - flunisolide - spray - 0.025% - flunisolide 0.025% - corticosteroids

Canada - English - Health Canada

apotex inc - flunisolide - metered-dose pump - 0.25mg - flunisolide 0.25mg - corticosteroids

Canada - English - Health Canada

ratiopharm inc division of teva canada limited - flunisolide - spray - 25mcg - flunisolide 25mcg - corticosteroids

Canada - English - Health Canada

novopharm limited - flunisolide - spray - 25mcg - flunisolide 25mcg - corticosteroids

United States - English - NLM (National Library of Medicine)

forest pharmaceuticals, inc. - flunisolide hemihydrate (unii: qk4dys664x) (flunisolide - unii:qk4dys664x) - aerosol, metered - 80 ug - aerospan inhalation aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. aerospan inhalation aerosol is also indicated for asthma patients requiring oral corticosteroid therapy, where adding aerospan inhalation aerosol may reduce or eliminate the need for oral corticosteroids. aerospan inhalation aerosol is not indicated for the relief of acute bronchospasm. aerospan inhalation aerosol is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. hypersensitivity to flunisolide or any of the ingredients of this preparation contraindicates the use of aerospan inhalation aerosol.